Product Description
Capitalise on the laureate science behind Cabotres 60, a polished and noble solution for advanced cancer therapy. Each bottle contains 30 film-coated tablets of 60 mg Cabozantinib, engineered specifically for adults battling advanced renal cell carcinoma, hepatocellular carcinoma, or medullary thyroid cancer. This prescription-only, oral medication blocks multiple receptor tyrosine kinases, disrupting tumor growth and angiogenesis. Ending soon: Order today to safeguard your treatment continuity. For optimal efficacy and safety, use under medical supervision only. Available for export, manufactured in India.
Exceptional Targeted Therapy for Oncology Use
CABOTRES CABOZANTINIB 60 Tablet is strictly prescribed for adult patients, serving as a cutting-edge oral therapy in oncology. The polished, white to off-white film-coated tablets target cancer at the molecular level, inhibiting key enzymes that contribute to tumor progression. As a targeted chemotherapy, its primary application is in treating advanced-stage kidney, liver, and thyroid cancers. The tablets are administered orally, enhancing patient comfort and compliance during cancer therapy.
Worldwide Supply and Reliable Delivery from India
Supplied directly from India's trusted exporter, manufacturer, and supplier, CABOTRES CABOZANTINIB 60 Tablet is available with stock ready for immediate dispatch. Ask for the current price for bulk supply, and secure your order before stock runs low. Standard packaging includes a bottle of 30 tablets, ensuring product integrity. The FOB port is in India, and delivery times are tailored to buyer needs for seamless procurement and ongoing treatment support.
FAQ's of CABOTRES CABOZANTINIB 60 Tablet:
Q: How should CABOTRES CABOZANTINIB 60 Tablet be administered?
A: This medication is to be taken orally as directed by a physician specializing in oncology. The exact dosage and duration depend on the specific diagnosis and patient condition. Always follow your healthcare provider's instructions.
Q: What is the primary benefit of using Cabotres 60 in cancer therapy?
A: Cabotres 60 offers potent, targeted inhibition of multiple tyrosine kinases, effectively slowing tumor growth and hindering new blood vessel formation in certain advanced cancers, which can improve treatment outcomes.
Q: When is CABOTRES CABOZANTINIB prescribed?
A: It is prescribed for adults diagnosed with advanced renal cell carcinoma, hepatocellular carcinoma, or medullary thyroid cancer. A prescription and ongoing medical supervision are mandatory.
Q: Where should CABOTRES CABOZANTINIB 60 Tablet be stored?
A: Store the product below 30C, protected from moisture and light, to maintain its efficacy and shelf life, which is 24 months from the manufacture date.
Q: What is the process for ordering CABOTRES CABOZANTINIB for export?
A: Interested parties can request the asking price and confirm supply availability. Orders are fulfilled from India with stock ready for prompt shipping, leveraging reliable export channels and secure packaging.
Q: How does the machine or process ensure tablet quality?
A: Advanced pharmaceutical processes and polished machinery are used to manufacture each tablet, ensuring consistent quality, film-coating integrity, and accurate dosing for optimal therapeutic results.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese